Clinical Trial Update: Topical Bethanechol for Improvement of Esophageal Dysmotility [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating topical bethanechol for improving esophageal dysmotility has completed and results have been posted. The study was sponsored by Augusta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Dysmotility

Drugs mentioned

• Bethanechol (topical) (bethanechol)

Snippet

Sponsor: Augusta University | Conditions: Esophageal Dysmotility | Phase 1 | Status: COMPLETED | Results posted: 2015-01-29